journal article·2015-12

Design of antimicrobial peptides conjugated biodegradable citric acid derived hydrogels for wound healing

Zhiwei Xie, Nikhil V. Aphale, Tejaswi D. Kadapure, Aniket S. Wadajkar, Sara Orr, Dipendra Gyawali, Guoying Qian, Kytai T. Nguyen, Jian Yang

Publisher page

Abstract

Abstract Wound healing is usually facilitated by the use of a wound dressing that can be easily applied to cover the wound bed, maintain moisture, and avoid bacterial infection. In order to meet all of these requirements, we developed an in situ forming biodegradable hydrogel (iFBH) system composed of a newly developed combination of biodegradable poly(ethylene glycol) maleate citrate (PEGMC) and poly(ethylene glycol) diacrylate (PEGDA). The in situ forming hydrogel systems are able to conform to the wound shape in order to cover the wound completely and prevent bacterial invasion. A 2k factorial analysis was performed to examine the effects of polymer composition on specific properties, including the curing time, Young's modulus, swelling ratio, and degradation rate. An optimized iFBH formulation was achieved from the systematic factorial analysis. Further, in vitro biocompatibility studies using adult human dermal fibroblasts (HDFs) confirmed that the hydrogels and degradation products are not cytotoxic. The iFBH wound dressing was conjugated and functionalized with antimicrobial peptides as well. Evaluation against bacteria both in vitro and in vivo in rats demonstrated that the peptide‐incorporated iFBH wound dressing offered excellent bacteria inhibition and promoted wound healing. These studies indicated that our in situ forming antimicrobial biodegradable hydrogel system is a promising candidate for wound treatment. © 2015 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 3907–3918, 2015.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Wound Healing and Treatments · Antimicrobial Peptides and Activities · Antimicrobial agents and applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Biomedical Engineering Materials Research Institute, the Huck Institutes of the Life Sciences, the Pennsylvania State University University Park Pennsylvania 16802

Department of Bioengineering the University of Texas at Arlington Arlington Texas 76019

Joint Biomedical Engineering Program between the University of Texas at Arlington and the University of Texas Southwestern Medical Center Dallas Texas 75390

Department of Biology, College of Biological and Environmental Sciences Zhejiang Wanli University Ningbo 315100 China

Funding

Norman Hackerman Advanced Research Program (ARP) · National Institutes of Health · National Science Foundation Awards

References (40)

Show source-provided references
1. 10.1016/j.suc.2010.08.00110.1016/j.suc.2010.08.001 ↗
2. 10.1016/j.jaad.2007.08.04810.1016/j.jaad.2007.08.048 ↗
3. 10.1590/S1807-5932200600060001410.1590/S1807-59322006000600014 ↗
4. 10.1586/17434440.1.1.2110.1586/17434440.1.1.21 ↗
5. 10.1016/j.biomaterials.2005.04.01210.1016/j.biomaterials.2005.04.012 ↗
6. The basic principles of wound care
7. 10.1016/j.actbio.2011.02.01810.1016/j.actbio.2011.02.018 ↗
8. 10.1002/jbm.a.1010610.1002/jbm.a.10106 ↗
9. 10.1016/j.msec.2013.02.03110.1016/j.msec.2013.02.031 ↗
10. 10.1016/j.biomaterials.2010.08.02210.1016/j.biomaterials.2010.08.022 ↗
11. 10.1039/C2BM00026A10.1039/C2BM00026A ↗
12. 10.1016/j.biomaterials.2008.07.03410.1016/j.biomaterials.2008.07.034 ↗
13. 10.1128/AAC.47.9.2804-2809.200310.1128/AAC.47.9.2804-2809.2003 ↗
14. 10.1016/j.coph.2006.04.00610.1016/j.coph.2006.04.006 ↗
15. 10.1038/nbt126710.1038/nbt1267 ↗
16. 10.1016/S0927-7765(02)00151-010.1016/S0927-7765(02)00151-0 ↗
17. 10.1016/j.burns.2006.06.01010.1016/j.burns.2006.06.010 ↗
18. 10.1097/00002480-199811000-0000310.1097/00002480-199811000-00003 ↗
19. 10.1016/j.actbio.2013.07.03010.1016/j.actbio.2013.07.030 ↗
20. 10.1111/j.1067-1927.2004.12601.x10.1111/j.1067-1927.2004.12601.x ↗
21. 10.1111/j.1553-2712.2009.00439.x10.1111/j.1553-2712.2009.00439.x ↗
22. 10.1016/j.carbpol.2008.02.01710.1016/j.carbpol.2008.02.017 ↗
23. 10.1016/j.nano.2008.11.00310.1016/j.nano.2008.11.003 ↗
24. 10.1016/j.biotechadv.2011.01.00510.1016/j.biotechadv.2011.01.005 ↗
25. 10.1002/jbm.125910.1002/jbm.1259 ↗
26. 10.1089/ten.2006.12.60110.1089/ten.2006.12.601 ↗
27. Wound healing mediator production by human dermal fibroblasts grown within a collagen‐GAG matrix for skin repair in humans
28. 10.1016/j.actbio.2010.04.01110.1016/j.actbio.2010.04.011 ↗
29. 10.1021/bm020121m10.1021/bm020121m ↗
30. 10.1016/j.biomaterials.2010.08.03510.1016/j.biomaterials.2010.08.035 ↗
31. 10.1016/j.biomaterials.2010.05.00510.1016/j.biomaterials.2010.05.005 ↗
32. Preparing the wound bed 2003: Focus on infection and inflammation
33. 10.1038/nrmicro247410.1038/nrmicro2474 ↗
34. 10.1016/j.tibtech.2010.07.00610.1016/j.tibtech.2010.07.006 ↗
35. 10.1038/sj.jid.570059910.1038/sj.jid.5700599 ↗
36. 10.1002/jps.2119810.1002/jps.21198 ↗
37. 10.1021/bm201707z10.1021/bm201707z ↗
38. 10.3389/fbioe.2014.0002310.3389/fbioe.2014.00023 ↗
39. 10.1021/la802447v10.1021/la802447v ↗
40. 10.1002/adfm.20090010710.1002/adfm.200900107 ↗